GENE ONLINE|News &
Opinion
Blog

2018-03-07|

7 March, 1938: American biologist David Baltimore was born

by GeneOnline
Share To

American biologist David Baltimore (7 March, 1938 – present) is currently the President Emeritus and Robert Andrews Millikan Professor of Biology. After Renato Dulbecco discovered that tumor viruses operate by incorporating their DNA into the DNA of host cells, David Baltimore and Howard Temin – independently of one another – discovered that viruses with genomes consisting of RNA can also be inserted into host cells’ DNA. This takes place through an enzyme known as “reverse transcriptase”. The discovery that the information in RNA can be transferred to DNA meant that the generally accepted rule that genetic information was only transferred in one direction – from DNA to RNA, to protein – had to be modified. This finding led them to the Nobel Prize in Physiology or Medicine in 1975. David Baltimore was only 37 that year.

Reference
https://www.bbe.caltech.edu/content/david-baltimore

Image Source
https://commons.wikimedia.org/wiki/File:Dr._David_Baltimore1.jpg#file

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Research and Innovation at Academia Sinica: Taiwan’s Hub for Interdisciplinary Integration in Science and Technology
2024-12-18
Google DeepMind Open-Sources AlphaFold 3: A Game-Changer for Drug Discovery and Biotech
2024-11-12
Pioneers of AI Win Nobel Prize in Physics for Training Neural Networks with Physics
2024-10-09
LATEST
AACR Annual Meeting 2025: Cancer Research Innovations, NIH Funding Advocacy, and AI-Driven Advances
2025-04-28
Senti Biosciences to Showcase New Cell & GeneTherapy Data at AACR Annual Meeting 2025
2025-04-27
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top